One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Emerging β-lactam and β-lactamase inhibitor strategies for complicated urinary tract infections
Vaccine impact in Gavi-supported countries: balancing evidence with policy needs
A WHO worth fighting for: the case for focused, ambitious reform
Damage to Pasteur Institute of Iran threatens regional health security
FRESHAIR4Life: youth advocacy restoring trust in health institutions
Conversational AI and the amplified trust paradox in health care
Proton versus photon therapy for oropharyngeal cancer – Authors' reply
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
